Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for TELA Bio, Inc. (TELA : NSDQ)
 
 • Company Description   
TELA Bio Inc. is a commercial stage medical technology company. It is focused on the designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices. TELA Bio Inc. is headquartered in Malvern, Pennsylvania.

Number of Employees: 209

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.04 Daily Weekly Monthly
20 Day Moving Average: 86,505 shares
Shares Outstanding: 39.56 (millions)
Market Capitalization: $80.69 (millions)
Beta: 0.90
52 Week High: $5.18
52 Week Low: $0.86
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 4.62% -1.05%
12 Week 117.02% 82.07%
Year To Date -32.45% -36.73%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1 GREAT VALLEY PARKWAY SUITE 24
-
MALVERN,PA 19355
USA
ph: 484-320-2930
fax: -
ir@telabio.com http://www.telabio.com
 
 • General Corporate Information   
Officers
Antony Koblish - President; Chief Executive Officer and Director
Doug Evans - Chairman; Board of Directors
Roberto Cuca - Chief Operating Officer and Chief Financial Office
Megan Smeykal - Chief Accounting Officer and Controller
Kurt Azarbarzin - Director

Peer Information
TELA Bio, Inc. (CORR.)
TELA Bio, Inc. (RSPI)
TELA Bio, Inc. (CGXP)
TELA Bio, Inc. (BGEN)
TELA Bio, Inc. (GTBP)
TELA Bio, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 872381108
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/11/25
Share - Related Items
Shares Outstanding: 39.56
Most Recent Split Date: (:1)
Beta: 0.90
Market Capitalization: $80.69 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.16 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.71 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.45
Price/Cash Flow: -
Price / Sales: 1.13
EPS Growth
vs. Year Ago Period: -8.70%
vs. Previous Quarter: -8.70%
Sales Growth
vs. Year Ago Period: 11.55%
vs. Previous Quarter: 4.94%
ROE
06/30/25 - -
03/31/25 - -402.45
12/31/24 - -383.78
ROA
06/30/25 - -
03/31/25 - -62.73
12/31/24 - -55.72
Current Ratio
06/30/25 - -
03/31/25 - 4.22
12/31/24 - 5.01
Quick Ratio
06/30/25 - -
03/31/25 - 3.40
12/31/24 - 4.19
Operating Margin
06/30/25 - -
03/31/25 - -61.00
12/31/24 - -54.60
Net Margin
06/30/25 - -
03/31/25 - -61.00
12/31/24 - -54.60
Pre-Tax Margin
06/30/25 - -
03/31/25 - -61.13
12/31/24 - -54.81
Book Value
06/30/25 - -
03/31/25 - 0.46
12/31/24 - 0.72
Inventory Turnover
06/30/25 - -
03/31/25 - 1.74
12/31/24 - 1.68
Debt-to-Equity
06/30/25 - -
03/31/25 - 2.28
12/31/24 - 1.45
Debt-to-Capital
06/30/25 - -
03/31/25 - 69.49
12/31/24 - 59.10
 

Powered by Zacks Investment Research ©